July 24, 2026

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

A review of the scientific literature on the impact of environmental factors on the health of pediatric cancer survivors by Omar Shakeel, MD, Assistant Professor in the Department of Pediatrics, Divis...

The ASCO Post

July 24, 2026

AACR Cancer Disparities Progress Report: Trends Show Mortality Rates Improve But Inequity in Care Remains

The American Association for Cancer Research (AACR) released its Cancer Disparities Progress Report 2026, featuring updates on the unprecedented progress against cancer. At the same time, the report n...

The ASCO Post

July 22, 2026

AI-Derived Bone Marrow Architecture Score Improves Disease Assessment in Myelodysplastic Neoplasms

Mapping bone marrow architecture using an artificial intelligence (AI)-derived score provided a more accurate view of disease state in myelodysplastic neoplasms (MDS) than molecular or blast-based ass...

The ASCO Post

July 22, 2026

Early Research Examines Daraxonrasib in NRAS-Mutant Melanoma

Preclinical research showed antiproliferative activity against NRAS-mutant melanoma cell lines and antitumor activity against preclinical melanoma models.

The ASCO Post

July 20, 2026

National Survey Links Civic Engagement to Higher Breast Cancer Screening Rates

Findings from a National Health Interview Survey revealed that civically engaged adults were more likely to stay up to date with their breast cancer screenings. The research findings were published in...

The ASCO Post

July 17, 2026

Tumor Microenvironment Ecotypes May Explain Differences in Multiple Myeloma Outcomes

“Our delineation of five distinct tumor microenvironment ecotypes in the bone marrows of patients with plasma cell disorders provides a new framework to understand the critical role of the host immune...

The ASCO Post

July 16, 2026

Digital Check-ins May Improve Outcomes in Patients Undergoing Treatment for Advanced Cancer

Researchers found that the biggest improvements were seen among patient groups that have historically faced the greatest barriers to care, including Black patients and individuals with less formal edu...

The ASCO Post

July 15, 2026

Setmelanotide in Patients With Acquired Hypothalamic Obesity

Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The ...

The ASCO Post

July 14, 2026

American Cancer Society Reports Latest Global Cancer Statistics

New data published in Global Cancer Statistics, 2026 reveal stark geographic inequities and underscore the urgent need for global action on prevention, early detection, and equitable treatment access.

The ASCO Post

July 14, 2026

Adjuvant Selpercatinib Deemed ‘Immediately Practice-Changing’ in Early-Stage RET Fusion–Positive NSCLC

The phase III LIBRETTO-432 trial of adjuvant therapy with the central nervous system (CNS)–penetrant oral RET inhibitor selpercatinib met its primary endpoint of improved event-free survival in patien...

The ASCO Post